IRIS
CIPRIANI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.036
EU - Europa 4.338
AS - Asia 1.910
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 15
SA - Sud America 10
AF - Africa 3
Totale 13.332
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.015
IE - Irlanda 1.624
CN - Cina 1.001
TR - Turchia 677
SE - Svezia 588
IT - Italia 527
DE - Germania 445
UA - Ucraina 398
GB - Regno Unito 306
FI - Finlandia 170
FR - Francia 163
SG - Singapore 127
IN - India 48
BE - Belgio 38
VN - Vietnam 34
CZ - Repubblica Ceca 20
CA - Canada 18
AU - Australia 14
EU - Europa 14
NL - Olanda 10
GR - Grecia 7
ES - Italia 6
NZ - Nuova Zelanda 6
BR - Brasile 5
MK - Macedonia 5
RU - Federazione Russa 5
CH - Svizzera 4
RO - Romania 4
JP - Giappone 3
KR - Corea 3
AT - Austria 2
BG - Bulgaria 2
CO - Colombia 2
DK - Danimarca 2
HK - Hong Kong 2
ID - Indonesia 2
IL - Israele 2
IR - Iran 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NO - Norvegia 2
PE - Perù 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CL - Cile 1
EG - Egitto 1
GE - Georgia 1
HU - Ungheria 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
PH - Filippine 1
PL - Polonia 1
PR - Porto Rico 1
PT - Portogallo 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 13.332
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.642
Dublin 1.618
Chandler 1.609
Izmir 403
Boardman 296
Nanjing 273
New York 251
Wilmington 246
Lawrence 235
Princeton 235
San Mateo 225
Ann Arbor 196
Ashburn 167
L'aquila 129
Beijing 127
Nanchang 99
Milan 93
Singapore 87
Dearborn 85
Woodbridge 82
Seattle 70
Shenyang 64
Los Angeles 53
Des Moines 52
Verona 49
Kunming 45
Mountain View 43
Hebei 42
Jiaxing 40
Shanghai 35
Brussels 34
Dong Ket 34
Jinan 34
Tianjin 31
Changsha 29
Zhengzhou 29
L’Aquila 28
Dallas 27
Norwalk 27
Pune 23
Hefei 22
Philadelphia 22
Helsinki 20
Rome 20
Hangzhou 19
Brno 18
Ningbo 18
Kitzingen 15
Guangzhou 14
Houston 14
Munich 13
Lanzhou 11
Bremen 10
Cedar Knolls 10
Redwood City 10
Changchun 9
Taizhou 9
Washington 9
Auburn Hills 8
Falls Church 8
Grafing 8
Edinburgh 7
Fremont 7
Phoenix 7
Frankfurt am Main 6
Jinhua 6
Lappeenranta 6
Reggio Nell'emilia 6
Berlin 5
Pescara 5
Brisbane 4
Fuzhou 4
La Spezia 4
Leuven 4
Redmond 4
Stockholm 4
Auckland 3
Bari 3
Castelfranco Veneto 3
Chengdu 3
Chicago 3
Fairfield 3
Florence 3
Forest City 3
London 3
Madrid 3
Melbourne 3
Naples 3
Napoli 3
New Delhi 3
Orange 3
Ottawa 3
Padova 3
Paris 3
Santa Clara 3
Skopje 3
Tappahannock 3
Vigevano 3
Zurich 3
Amsterdam 2
Totale 9.324
Salva come PNG Salva come JPEG
Nome #
Aumento dei linfociti circolanti gamma-delta Vdelta1+ in corso di malattie infiammatorie intestinali 127
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 109
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 99
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 97
Studio dell’espressione della chemochina SDF-1 e del suo recettore CXCR4 nella cute e nelle cellule endoteliali microvascolari di pazienti affetti da sclerosi sistemica (SSc). 94
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 93
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 93
Prognostic factors of adult onset Still’s disease: analysis of 100 cases in 3 tertiary referral centers 92
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 90
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 89
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients. 89
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome. 89
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 88
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 88
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 88
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 86
Linfociti T Gamma-Delta (G/D) in pazienti con malattie infiammatorie intestinali (IBD) 84
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 84
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 81
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis 80
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 80
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 79
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease 78
Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis 78
Stem cell therapies for systemic sclerosis 77
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?' 76
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 76
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 76
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 75
Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18. 74
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 74
GAMMA/DELTA T CELL APOPTOSIS IN SYSTEMIC SCLEROSIS PATIENTS 74
EFFICACY AND SAFETY OF RITUXIMAB TREATMENT IN EARLY PRIMARY SJOGREN'S SYNDROME: A CLINICAL, HISTOLOGICAL AND MOLECULAR STUDY 73
Cardiovascular disease in primary sjögren’s syndrome 73
Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms 72
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 72
T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives. 72
Combined approach to the initial stage raynaud’s phenomenon diagnosis by means of dynamic digital telehermograpy, capillaroscopy and pletismography. Preliminary findings. 71
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 71
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 71
Unmasking the pathogenic role of il-17 axis in primary sj¨ogren’s syndrome: A new era for therapeutic targeting? 71
Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature. 70
Circulating gamma/delta T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization 70
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 70
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.. Epub 2002 Aug 30 69
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 69
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 69
Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis 69
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. 69
Combined approach to the initial stage raynaud's phenomenon diagnosis by means of dynamic digital telethermography, capillaroscopy and pletismography preliminary findings. 68
DUO Registry Group. Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO Registry. 68
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 68
Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from Ssc Patients Induces an Anti Angiogenetic Effect, when Co-cultured with Endothelial Cells 67
EFFETTI DEI CAMPI ELETTROMAGNETICI LENTAMENTE VARIABILI SU SPERMATOZOI UMANI. VII CONGRESSO AIBG, ASSOCIA-ZIONE ITALIANA DI BIOLOGIA E GENETICA GENERALE E MOLECOLARE 67
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. 67
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study. 66
Interstitial lung disease in systemic sclerosis: current and future treatment. 66
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 65
FAS -670 gene promoter polymorphism confers susceptibility to systemic sclerosis 65
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. 65
Combination therapy with cyclosporine and methotrexate in patients with earlyrheumatoid arthritis soon inhibits TNFa production without . decreasing TNFa mRNA levels. An in vivo and in vitro stufy 64
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 64
Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: the experience of two Italian integrated Dermatology/Rheumatology outpatient clinics. 63
High levels of NK cells in the peripheral blood of patients affected with anti-phospholipid syndrome and recurrent spontaneous abortion: a potential new hypothesis 63
Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1. 63
Increase of circulating gamma/delta T lymphocytes in the peripheral blood of patients affected by active inflammatory bowel disease 63
Endothelial progenitor cells: Are they displaying a function in autoimmune disorders? 63
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 63
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. 63
CD4(-)CD8(-) T-cells in primary Sjögren's syndrome: association with the extent of glandular involvement. 63
Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis 62
SDF-1 expression in the skin of SSc patients. 62
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 62
Gamma-delta T cells are not involved in the natural and antibody-dependent cytotoxicity of peripheral blood mononuclear cells in inflammatory bowel disease. 62
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy. 62
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 61
LONG-TERM SURVIVAL OF ANTI-TNF THERAPY IN A LARGE ITALIAN COHORT OF RHEUMATOID ARTHRITIS PATIENTS: COMPARISON AMONG ADALIMUMAB, ETANERCEPT, AND INFLIXIMAB. 61
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 61
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 61
Myositis in primary Sjögren's syndrome: data from a multicentre cohort. 60
Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's disease (CD). 60
Variations of neuronal nitric oxide synthase in systemic sclerosis skin 60
 T cells in placenta and skin: their different functions may support the paradigm of microchimerism in systemic sclerosi 60
LONG-TERM ANTI-TNF THERAPY AND RISK OF SERIOUS INFECTIONS IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS: COMPARISON AMONG ADALIMUMAB, ETANERCEPT AND INFLIXIMAB. ANNALS OF THE RHEUMATIC DISEASES 60
IL-6 production from peripheral blood mononuclear cells (PBMC) of patients affected by progressive systemic sclerosis (PSS). 60
Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: A pilot study 60
Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation? 60
Methotrexate: an old new drug in autoimmune disease. 59
SDF-1/CXCR4 system in microvascular endothelial cells and skin from patients affected by systemic sclerosi 59
Activation antigens and adhesion molecules expression on Vd1+ T cells in systemic sclerosis (SSc) 59
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 59
Inhibition of the complement system by glutathione: molecular mechanisms and potential therapeutic implications. 59
Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC) 59
Cellular players in angiogenesis during the course of systemic sclerosis. 59
Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor 59
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. 59
Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion 58
Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis 58
Espressione di antigeni di attivazione e molecole di adesione nei linfociti Vd1+ di pazienti affetti da sclerosi sistemica. 58
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 58
Totale 7.119
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.107
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.107
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.508 0 25 225 21 36 270 298 42 222 74 21 274
2020/20211.915 37 225 21 243 245 86 254 20 236 73 371 104
2021/20221.310 74 88 249 96 33 19 28 63 108 68 93 391
2022/20234.607 336 251 82 479 395 489 31 298 2.013 30 143 60
2023/20241.248 168 74 82 157 106 363 25 73 9 57 36 98
2024/2025172 114 58 0 0 0 0 0 0 0 0 0 0
Totale 13.660